Nonselective endothelin receptor antagonist initiated soon after the onset of myocardial infarction may deteriorate 24-hour survival

Journal of Cardiovascular Pharmacology

Volumn 38, Issue 1, 2001, Pages 29-38

  Takahashi, Chikako ^a   Kagaya, Yutaka ^a   Namiuchi, Shigeto ^a   Takeda, Morihiko ^a   Fukuchi, Mitsumasa ^a   Otani, Hiroki ^a   Ninomiya, Mototsugu ^a   Yamane, Yuriko ^a   Kohzuki, Masahiro ^a   Watanabe, Jun ^a   Shirato, Kunio ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Endothelin; Endothelin receptor antagonist; Left ventricular remodeling; Myocardial infarction

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; TAK 044;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BOLUS INJECTION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART INFARCTION; HEART LEFT VENTRICLE DP-DT; HEART VENTRICLE REMODELING; HEART WEIGHT; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BLOOD PRESSURE; ENDOTHELIN-1; MALE; MYOCARDIAL INFARCTION; PEPTIDES, CYCLIC; RATS; RATS, WISTAR; RECEPTORS, ENDOTHELIN; VENTRICULAR REMODELING;

EID: 0034932967     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200107000-00004     Document Type: Article

References (36)

1. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
2. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes: A paracrine mechanism for myocardial cell hypertrophy
3. Effects of endothelins on collagen turnover in cardiac fibroblasts
4. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure: Marked increase in endothelin-1 production in the failing heart
5. Endothelin in human congestive heart failure
6. Role of endogenous endothelin in chronic heart failure: Effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling
7. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure
8. Aggravation of left ventricular remodeling by a novel specific endothelin ET(A) antagonist EMD94246 in rats with experimental myocardial infarction
9. Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat
10. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: Possible involvement of myocardial endothelin system in ventricular remodeling
11. Myocardial infarct size and ventricular function in rats
12. Regional and temporal profiles of phorbol 12,13-dibutyrate binding after myocardial infarction in rats: Effects of captopril treatment
13. B
14. Effects of long-term pressure overload on regional myocardial glucose and free fatty acid uptake in rats: A quantitative autoradiographic study
15. Immunological characterization of the subunit of the 100 Å filaments from muscle cells
16. Specific sandwich-type enzyme immunoassays for smooth muscle constricting novel 31-amino acid endothelins
17. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: Their relation to lesion site and beta-adrenergic receptor therapy
18. Role of endogenous endothelin in the extension of myocardial infarct size studied with the endothelin receptor antagonist, TAK-044
19. B-mediated blood pressure responses in rats
20. Increased endothelin in experimental heart failure
21. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats
22. Role of Na(+)-H+ exchange in mediating effects of endothelin-1 on normal and ischemic/reperfused hearts
23. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure
24. Update of REACH-1 and MERIT-HF clinical trials in heart failure
25. Cardiac hypertrophy: Mechanical, neural, and endocrine dependence
26. B receptors, and ECE and distribution of endothelin-1 in failing rat heart
27. Endothelin receptors in cultured adult rat cardiac fibroblasts
28. B receptors mediate contraction to endothelin-1 in human blood vessels
29. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells
30. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors
31. Role of bradykinin-NO pathway in prevention of cardiac hypertrophy by ACE inhibitor in rat cardiomyocytes
32. Reduced pulmonary clearance of endothelin-1 contributes to the increase of circulating levels in heart failure secondary to myocardial infarction
33. B receptors in rats
34. Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure
35. B receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney
36. Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction